Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
1 other identifier
observational
250
1 country
1
Brief Summary
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2021
CompletedStudy Start
First participant enrolled
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 3, 2026
June 1, 2026
5 years
August 31, 2021
June 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse Events at 5 days
Composite of recurrent/worsening VTE (including PE or DVT), new cardiac dysrhythmia, major bleeding, return to the ED, death or need for critical interventions (including advanced cardiac life support, advanced respiratory support, vasopressor support, thrombolysis or new oxygen requirement occurring after initial presentation) occurring within 5 days of acute PE diagnosis
Within 5 days of presentation/enrollment
Secondary Outcomes (3)
Adverse Events during Index Hospitalization
Between time of presentation/enrollment and discharge from index hospitalization
Adverse Events within 14 days
Within 14 days of presentation/enrollment
Adverse Events within 30 days
Within 30 days of presentation/enrollment
Study Arms (1)
Acute Pulmonary Embolism
Subjects in this single cohort will undergo point-of-care echocardiography at the time of presentation and subsequent follow up to assess for short term adverse events or complications.
Interventions
Subjects will undergo point-of-care echocardiography at the time of presentation/enrollment to assess for evidence of right sided heart dilation/strain.
Eligibility Criteria
The study population consists of ED patients over the age of 18 who have an acute pulmonary embolism identified on CT imaging.
You may qualify if:
- Age \>= 18 years of age
- ED diagnosis of acute pulmonary embolism with identification on CT imaging
You may not qualify if:
- Age \<18 years of age
- Inability to provide informed consent
- Incarceration
- Current PE previously diagnosed prior to index ED visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- WellSpan Healthlead
- Stony Brook Universitycollaborator
- University of California, Irvinecollaborator
Study Sites (1)
Wellspan York Hospital
York, Pennsylvania, 17403, United States
Related Publications (11)
Alerhand S, Hickey SM. Tricuspid Annular Plane Systolic Excursion (TAPSE) for Risk Stratification and Prognostication of Patients with Pulmonary Embolism. J Emerg Med. 2020 Mar;58(3):449-456. doi: 10.1016/j.jemermed.2019.09.017. Epub 2019 Nov 15.
PMID: 31735658BACKGROUNDAujesky D, Perrier A, Roy PM, Stone RA, Cornuz J, Meyer G, Obrosky DS, Fine MJ. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med. 2007 Jun;261(6):597-604. doi: 10.1111/j.1365-2796.2007.01785.x.
PMID: 17547715BACKGROUNDCarley S, Dosman S, Jones SR, Harrison M. Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J. 2005 Mar;22(3):180-1. doi: 10.1136/emj.2003.011148.
PMID: 15735264BACKGROUNDChan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost. 2010 Jul;8(7):1509-14. doi: 10.1111/j.1538-7836.2010.03888.x. Epub 2010 Apr 16.
PMID: 20403093BACKGROUNDCiurzynski M, Kurnicka K, Lichodziejewska B, Kozlowska M, Plywaczewska M, Sobieraj P, Dzikowska-Diduch O, Goliszek S, Bienias P, Kostrubiec M, Pruszczyk P. Tricuspid Regurgitation Peak Gradient (TRPG)/Tricuspid Annulus Plane Systolic Excursion (TAPSE) - A Novel Parameter for Stepwise Echocardiographic Risk Stratification in Normotensive Patients With Acute Pulmonary Embolism. Circ J. 2018 Mar 23;82(4):1179-1185. doi: 10.1253/circj.CJ-17-0940. Epub 2018 Jan 26.
PMID: 29375106BACKGROUNDDaley J, Grotberg J, Pare J, Medoro A, Liu R, Hall MK, Taylor A, Moore CL. Emergency physician performed tricuspid annular plane systolic excursion in the evaluation of suspected pulmonary embolism. Am J Emerg Med. 2017 Jan;35(1):106-111. doi: 10.1016/j.ajem.2016.10.018. Epub 2016 Oct 11.
PMID: 27793505BACKGROUNDDonze J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, Aujesky D. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008 Nov;100(5):943-8. doi: 10.1160/th08-05-0285.
PMID: 18989542BACKGROUNDHariharan P, Takayesu JK, Kabrhel C. Association between the Pulmonary Embolism Severity Index (PESI) and short-term clinical deterioration. Thromb Haemost. 2011 Apr;105(4):706-11. doi: 10.1160/TH10-09-0577. Epub 2011 Jan 12.
PMID: 21225095BACKGROUNDKurzyna M, Torbicki A, Pruszczyk P, Burakowska B, Fijalkowska A, Kober J, Oniszh K, Kuca P, Tomkowski W, Burakowski J, Wawrzynska L. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol. 2002 Sep 1;90(5):507-11. doi: 10.1016/s0002-9149(02)02523-7.
PMID: 12208411BACKGROUNDRydman R, Soderberg M, Larsen F, Alam M, Caidahl K. d-Dimer and simplified pulmonary embolism severity index in relation to right ventricular function. Am J Emerg Med. 2013 Mar;31(3):482-6. doi: 10.1016/j.ajem.2012.09.016. Epub 2012 Nov 12.
PMID: 23154103BACKGROUNDShafiq Q, Moukarbel GV, Gupta R, Hernandez DA, Khouri SJ. Practical echocardiographic approach for risk stratification of patients with acute pulmonary embolism. J Echocardiogr. 2016 Dec;14(4):146-155. doi: 10.1007/s12574-016-0306-4. Epub 2016 Aug 10.
PMID: 27510333BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brent A Becker, MD
WellSpan Health
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Director, Department of Emergency Medicine
Study Record Dates
First Submitted
August 31, 2021
First Posted
September 20, 2021
Study Start
September 9, 2021
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 3, 2026
Record last verified: 2026-06